patritumab deruxtecan (U3-1402) - Daiichi Sankyo, Merck (MSD)
DM002 - Doma Pharma, Biocytogen
https://www.abstractsonline.com/pp8/#!/20272/presentation/6182
 
Y. Zhang 1; C. Shang 1; N. Wang 2; G. An 1; C. Guo 1; W. An 1; Y. Yang1
 
Mar 6, 2024
 
Next